You are a Pharma company which has a product in the weight loss area. But over the years the company has only gained a nominal market share. The strategy team has decided to position the product in Diabetes space as the main indication and weight loss as minor indication. How will you help to market this idea to the HCPs? How will you overcome the existing position of the drug in the market?

In a crowded anti-diabetic landscape, you take a bold step to enter the competitive diabetes market. With established players already ruling the roost and doctors accustomed to prescribing their trusted brands, you will face an enormous challenge. Amidst fierce competition how will you prove your product’s efficacy, create brand awareness, establish a foothold in the doctor’s mind and thereby influence their intent to prescribe?

You have a well-established anti-diabetic brand and for years it has been a trusted name among HPCs. However, the once-soaring profits have now begun to plateau. Despite the efforts, the sales representatives, the frontline connection with HCPs, couldn’t provide any insights into this stagnation. How will you learn the current perception of your brand by HCPs? What do the HCPs want? What are their interest areas? What treatment options are they looking at?

A new department of diabetology of well-established company has reached an impasse regarding their sales strategy. In the current situation the company is relying mostly on the dealers appointed in different locations for their sales. But the dealers are a little reluctant to push their products given the nascent phase of the department. Should the company invest in hiring new sales reps for better penetration in the HCP space or should they invest in a digital marketing plan?

In the competitive realm of diabetes medications, you are in a unique situation. Among your trio of diabetes drugs, one, Medicine A, shone brightly, capturing the attention of doctors. Unfortunately, Medicines B and C, though effective, remained in the background. The challenge lay in the brief 2-minute window the sales reps had with doctors, allowing discussion about only one medicine. This left the other two silently waiting and their potential untapped. Is there a way to increase the uptake of the other two medicines? Should you consider trying some other communication channel for the other two drugs?

With 16.1% prevalence of diabetes in urban India, one of the leading pharma companies found success in metropolitan cities where their diligent sales representatives worked tirelessly. Their products were well-known among city doctors, leading to booming sales. However, beyond the cityscape, numerous doctors in non-metro cities remained untouched because there were no sales reps assigned there. This untapped potential represented a significant loss, as sales opportunities slipped away in regions where the company could have flourished. How do you access this non-metro market?